CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection.
CONCLUSION: The CD34+CD38-CD123+ phenotype is present in virtually all AML blasts and it may be used as a unique single phenotype for MRD detection in AML patients.
PMID: 29065396 [PubMed - as supplied by publisher]
Source: Acta Haematologica - Category: Hematology Authors: Al-Mawali A, Pinto AD, Al-Zadjali S Tags: Acta Haematol Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Hematology | Leukemia | Stem Cell Therapy | Stem Cells | Study